Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Jerome Stevens Pharmaceuticals, Inc.
FDA Inspection
•Jerome Stevens Pharmaceuticals, Inc.•November 23, 2010

Jerome Stevens Pharmaceuticals, Inc. – FDA Inspection, Nov 23, 2010

Record Details

This FDA Inspection record concerns Jerome Stevens Pharmaceuticals, Inc., with an inspection on November 23, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Jerome Stevens Pharmaceuticals, Inc.
Inspection Date
November 23, 2010
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 248b8a40-d653-4a6e-ba88-ebc73e0c127f

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
699938
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

10
  1. 21 CFR 211.103Actual vs. theoretical yields not determined
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  4. 21 CFR 211.46(b)Equipment for Environmental Control
  5. 21 CFR 211.160(b)Scientifically sound laboratory controls
  6. 21 CFR 211.198(a)Complaint Handling Procedure
  7. 21 CFR 211.42(b)Adequate space lacking to prevent mix-ups and contamination
  8. 21 CFR 211.42(b)Product flow through building is inadequate
  9. 21 CFR 211.130(a)Prevention of cross contamination, mix-ups
  10. 21 CFR 211.67(b)Written procedures not established/followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Jerome Stevens Pharmaceuticals, Inc.

11
DateClassificationOfficeProject area
August 1, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
June 15, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 11, 2019VAICenter for Drug Evaluation and ResearchPostmarket Surv. and Epidemiology
March 30, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 23, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 11 other inspections on the company page
Other documents for Jerome Stevens Pharmaceuticals, Inc.
  • FDA Inspection 1247238 - 2024-08-01
  • FDA Inspection 1171967 - 2022-06-15
  • FDA Inspection 1086248 - 2019-04-11
  • FDA Inspection 1009653 - 2017-03-30
  • FDA Inspection 935880 - 2015-07-23

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jerome Stevens Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.